4.8 Article

Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection

Journal

GUT
Volume 68, Issue 10, Pages 1791-1800

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/gutjnl-2018-317842

Keywords

-

Funding

  1. National Institute of Health Research (NIHR) Imperial Biomedical Research Centre (BRC) based at Imperial College Healthcare NHS Trust and Imperial College London
  2. NIHR BRC
  3. Medical Research Council (MRC) Clinical Research Training Fellowship [MR/R000875/1]
  4. Alberta Health Services
  5. University of Alberta Hospital Foundation
  6. Southern Ontario Academic Medical Organization
  7. National Institutes of Health [R33/AI21575]
  8. SFI [12/RC/2273, 16/ERA-HDHL/3358]
  9. Wellcome Trust [107660/Z/15Z]
  10. Royal Society [107660/Z/15Z]
  11. MRC [MC_PC_17162, MR/P028225/1, MR/R000875/1] Funding Source: UKRI
  12. Science Foundation Ireland (SFI) [16/ERA-HDHL/3358] Funding Source: Science Foundation Ireland (SFI)

Ask authors/readers for more resources

Objective Faecal microbiota transplant (FMT) effectively treats recurrent Clostridioides difficile infection (rCDI), but its mechanisms of action remain poorly defined. Certain bile acids affect C. difficile germination or vegetative growth. We hypothesised that loss of gut microbiota-derived bile salt hydrolases (BSHs) predisposes to CDI by perturbing gut bile metabolism, and that BSH restitution is a key mediator of FMT's efficacy in treating the condition. Design Using stool collected from patients and donors pre-FMT/post-FMT for rCDI, we performed 16S rRNA gene sequencing, ultra performance liquid chromatography mass spectrometry (UPLC-MS) bile acid profiling, BSH activity measurement, and qPCR of bsh/baiCD genes involved in bile metabolism. Human data were validated in C. difficile batch cultures and a C57BL/6 mouse model of rCDI. Results From metataxonomics, pre-FMT stool demonstrated a reduced proportion of BSH-producing bacterial species compared with donors/post-FMT. Pre-FMT stool was enriched in taurocholic acid (TCA, a potent C. difficile germinant); TCA levels negatively correlated with key bacterial genera containing BSH-producing organisms. Post-FMT samples demonstrated recovered BSH activity and bsh/baiCD gene copy number compared with pretreatment (p<0.05). In batch cultures, supernatant from engineered bsh-expressing E. coli and naturally BSH-producing organisms (Bacteroides ovatus, Collinsella aerofaciens, Bacteroides vulgatus and Blautia obeum) reduced TCA-mediated C. difficile germination relative to culture supernatant of wild-type (BSH-negative) E. coli. C. difficile total viable counts were similar to 70% reduced in an rCDI mouse model after administration of E. coli expressing highly active BSH relative to mice administered BSH-negative E. coli (p<0.05). Conclusion Restoration of gut BSH functionality contributes to the efficacy of FMT in treating rCDI.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available